Nevada PDMP Controlled Substance Privacy Law Compliance Checklist

Use this Nevada PDMP Controlled Substance Privacy Law Compliance Checklist to align prescribing, dispensing, and data practices with Board of Pharmacy Regulations and federal standards. It focuses on practical steps you can implement today to protect patient privacy while meeting controlled-substance obligations.

This material is informational and supports compliance planning; it does not replace legal counsel or regulatory guidance from state authorities.

Prescription Requirements for Controlled Substances

Quick compliance checks before prescribing

• Confirm a legitimate medical purpose and document the clinical rationale in the chart.
• Verify patient identity with two reliable identifiers and assess risk factors for misuse or diversion.
• Check the PDMP for recent fills, multiple prescribers, or early refills before issuing or renewing therapy.
• Match quantity, dose, and duration to the diagnosis; apply added caution for Controlled Substance Schedules II IV.
• Use electronic prescribing of controlled substances (EPCS) where applicable; if using paper, employ tamper‑resistant features.

Required elements on every controlled‑substance prescription

• Patient full name, address, and date of birth.
• Drug name, strength, dosage form, clear directions, and quantity (avoid ambiguous abbreviations).
• Days’ supply, intended indication when appropriate, and earliest fill date if clinically necessary.
• Prescriber name, practice address, phone, and DEA number; signature with date issued.
• Authorized refills consistent with the schedule and Board of Pharmacy Regulations.

Before‑issue safeguards

• Screen for drug–drug interactions and contraindications; consider non‑opioid or non‑controlled alternatives first.
• Discuss risks, benefits, safe storage, and disposal; offer naloxone when indicated.
• Document the PDMP check and clinical justification, especially for therapy beyond short‑term use.

Record-Keeping Obligations for Practitioners

What to keep

• Prescription Dispensing Records (originals and electronic images), including EPCS audit details.
• Inventory logs for controlled substances, receipt and distribution records, and wastage/destruction documentation.
• PDMP query logs or attestations, treatment agreements, informed consent forms, and risk assessments.
• Corrected/voided records and explanations for any unusual transactions or partial fills.

Retention and availability

• Retain records for the period required by Board of Pharmacy Regulations and federal law; keep them readily retrievable.
• Ensure records are organized by patient and date, with controls that prevent alteration after finalization.
• Designate a custodian who can produce records promptly during inspections or audits.

Security and organization

• Store paper records in restricted areas; encrypt digital repositories at rest and in transit.
• Apply role‑based access, multifactor authentication, and audit trails that flag unusual access or edits.
• Back up critical data on a scheduled cadence and test restoration regularly.

Prescription Monitoring Program Development

Governance and policy framework

• Establish a written policy for PDMP use that defines when to check, how to document, and escalation steps for red flags.
• Assign a privacy officer and PDMP administrator to oversee onboarding, audits, and sanctions for misuse.
• Integrate Controlled Substance Monitoring Program goals into your overall compliance plan.

Workflow design and training

• Embed PDMP checks into intake, refill, and renewal workflows with clear responsibility handoffs.
• Train prescribers, pharmacists, and delegates on appropriate use, PDMP Data Security, and confidentiality.
• Use standardized note templates to capture PDMP findings, clinical decisions, and patient counseling.

Technology enablement

• Enable EHR or pharmacy system integration for single sign‑on and in‑workflow PDMP access when available.
• Automate flags for multiple prescribers, overlapping therapies, and early refill patterns.
• Schedule internal audits to review access logs, identify anomalies, and retrain as needed.

PDMP Data Reporting Procedures

Prepare and validate your data

• Capture all required fields for each dispensing event, including patient, prescriber, and product details.
• Use standardized drug identifiers and consistent units of measure to prevent misclassification.
• Validate records for completeness and logical accuracy before submission.

Submit accurately and on time

• Report dispensing to the PDMP within the timeframe set by Board of Pharmacy Regulations.
• Follow the state‑specified transmission format and file naming conventions to reduce rejects.
• Send “no activity” or zero‑fill reports when required during periods without dispensing.

Maintain, correct, and reconcile

• Monitor submission acknowledgments and promptly correct rejected or erroneous records.
• Document amendments with who, what, when, and why to maintain a defensible audit trail.
• Reconcile internal dispensing totals against PDMP submissions to ensure completeness.

Protect the feed and repository

• Encrypt transmissions, restrict API credentials, and rotate keys per your PDMP Data Security policy.
• Limit access to reporting portals to trained staff; disable accounts immediately upon role changes.
• Periodically penetration‑test interfaces and remediate vulnerabilities.

PDMP Data Access and Confidentiality

Authorized users and purposes

• Prescribers and pharmacists may access PDMP data for treatment or dispensing decisions; trained delegates may assist under supervision.
• Licensing boards and oversight bodies may access for investigations consistent with law.
• Law enforcement may obtain data only through authorized legal process; access should be logged and reviewable.
• Patients may request their own PDMP history through the approved process.

Minimum necessary and auditability

• Access only the minimum data necessary to inform care or compliance tasks.
• Maintain immutable audit logs capturing user, timestamp, patient searched, and purpose of access.
• Review logs regularly; investigate outliers and document corrective actions.

Prevent and respond to misuse

• Ban credential sharing; require multifactor authentication and periodic password rotation.
• Educate staff on phishing and social engineering risks targeting PDMP portals.
• Establish a rapid response plan for potential breaches, including user suspension, containment, and notifications consistent with Board of Pharmacy Regulations.

Compliance with Federal Controlled Substance Laws

Align operations with CSA and DEA rules

• Maintain current DEA registration and keep it aligned with practice location and scope.
• Apply corresponding responsibility principles when evaluating prescriptions for validity before dispensing.
• Use DEA‑compliant ordering and record systems for Schedule II procurement and maintain perpetual inventory controls.

EPCS, telemedicine, and privacy intersections

• Use EPCS with identity proofing and two‑factor authentication for prescribers.
• Ensure telemedicine prescribing complies with federal requirements and document eligibility pathways.
• Coordinate HIPAA safeguards with PDMP Data Security and consider special rules for substance use disorder information.

Penalties for Non-Compliance

Administrative and licensing exposure

• Board of Pharmacy Regulations violations can trigger citations, fines, mandated corrective action, or license restrictions.
• State Board of Health Enforcement may coordinate sanctions where public health or privacy impacts are implicated.

Civil, criminal, and program consequences

• Late, inaccurate, or missing reports may result in civil penalties and corrective monitoring.
• Intentional diversion or falsification can lead to criminal charges and loss of professional licensure.
• Unauthorized PDMP Access Penalties may include access revocation, disciplinary action, and monetary fines.

Mitigation and remediation

• Self‑report substantive errors when appropriate, implement a written corrective action plan, and retrain involved staff.
• Strengthen controls, increase audit frequency, and verify effectiveness with documented follow‑up.

FAQs

What are the prescription requirements for controlled substances in Nevada?

Each prescription must contain complete patient and prescriber identifiers, the drug name and strength, clear directions, quantity, days’ supply, date issued, and prescriber signature. You should check the PDMP before initiating or renewing therapy, document the clinical purpose, use EPCS when applicable, and tailor refills and duration to the schedule—exercising added caution for Controlled Substance Schedules II IV under Board of Pharmacy Regulations.

How must PDMP data be reported and maintained?

Dispensers must submit accurate, complete dispensing data within the state’s required timeframe using the specified format. Maintain acknowledgments, correct rejects promptly, and file zero‑activity reports when required. Protect transmissions with encryption, restrict portal credentials, keep an audit trail for edits, and store Prescription Dispensing Records securely for the retention period set by regulation.

Who has authorized access to PDMP data?

Licensed prescribers, pharmacists, and designated delegates may access PDMP information for treatment or dispensing decisions. Licensing boards and oversight bodies may review data for investigations, and law enforcement may access only with proper legal authority. Patients can request their own records. All access must follow minimum‑necessary principles, be logged, and comply with PDMP Data Security requirements.

What penalties apply for failing to comply with PDMP laws?

Penalties range from administrative fines, mandated training, and access revocation to license discipline and, for intentional misuse or diversion, criminal liability. Violations tied to Unauthorized PDMP Access Penalties can be severe; prompt self‑correction, documentation, and strengthened controls reduce ongoing risk and demonstrate good‑faith compliance.